Intellipharmaceutics International Inc. (IPCI)

[Samsa]

I would agree with these estimates. I suspect, between 1.2 to 1.7 million for 4QE. Focalin sales have been stable so there is no reason we do not see the same revenue from that.

As for the recent 2 dose launch we will not see any improvement until 2QE18. the revenue for Focalin is received and reported in the next quarter. The timed the launch on the last day of the fiscal year so sales wont begin until 1QE18 which means revenue wont get reported until 2QE18.

Then, while we know the Bloomberg data has issues, we do know the scripts at least had doubled from the previous quarter so its a good guess that seroquel revenue will increase.

seeing that we posted 1.2 million in revenue last quarter, I feel its safe to assume 1.2 t 1.7. But again the analyst are setting us up for failure f not meeting expectations when they post unrealistic ones.